Thus, the relationship between CD40 expression and MG severity is most pronounced in TAMG, where local thymic immune dysregulation and CD40 pathway activation play a central role in driving severe, antibody-mediated disease [67,68]. This evidence concerns the gene CD40 and myasthenia gravis.